RAC3 expression is frequently elevated in a diverse range of human cancers, including colon carcinoma, lung adenocarcinoma, breast cancer, pancreatic cancer, and bladder cancer, which has been verified to be a crucial regulator in tumor initiation [35]. Here, RAC3 is linked to urinary bladder cancer.